Suppr超能文献

人肝癌干细胞中 microRNAs 的功能分析。

Functional analysis of microRNAs in human hepatocellular cancer stem cells.

机构信息

Department of Medicine and Scott & White Digestive Disease Research Center, Texas A&M Health Science Center College of Medicine and Scott & White Hospital, Temple, TX 76504, USA.

出版信息

J Cell Mol Med. 2012 Jan;16(1):160-73. doi: 10.1111/j.1582-4934.2011.01282.x.

Abstract

MicroRNAs are endogenous small non-coding RNAs that regulate gene expression and cancer development. A rare population of hepatocellular cancer stem cells (HSCs) holds the extensive proliferative and self-renewal potential necessary to form a liver tumour. We postulated that specific transcriptional factors might regulate the expression of microRNAs and subsequently modulate the expression of gene products involved in phenotypic characteristics of HSCs. We evaluated the expression of microRNA in human HSCs by microarray profiling, and defined the target genes and functional effects of two groups of microRNA regulated by IL-6 and transcriptional factor Twist. A subset of highly chemoresistant and invasive HSCs was screened with aberrant expressions of cytokine IL-6 and Twist. We demonstrated that conserved let-7 and miR-181 family members were up-regulated in HSCs by global microarray-based microRNA profiling followed by validation with real-time polymerase chain reaction. Importantly, inhibition of let-7 increases the chemosensitivity of HSCs to sorafenib and doxorubicin whereas silencing of miR-181 led to a reduction in HSCs motility and invasion. Knocking down IL-6 and Twist in HSCs significantly reduced let-7 and miR-181 expression and subsequently inhibited chemoresistance and cell invasion. We showed that let-7 directly targets SOCS-1 and caspase-3, whereas miR-181 directly targets RASSF1A, TIMP3 as well as nemo-like kinase (NLK). In conclusion, alterations of IL-6- and Twist-regulated microRNA expression in HSCs play a part in tumour spreading and responsiveness to chemotherapy. Our results define a novel regulatory mechanism of let-7/miR-181s suggesting that let-7 and miR-181 may be molecular targets for eradication of hepatocellular malignancies.

摘要

微小 RNA 是调节基因表达和癌症发展的内源性小型非编码 RNA。肝癌干细胞(HSCs)的一个稀有群体具有广泛的增殖和自我更新潜力,是形成肝肿瘤所必需的。我们假设特定的转录因子可能调节微小 RNA 的表达,从而调节参与 HSCs 表型特征的基因产物的表达。我们通过微阵列分析评估了人 HSCs 中微小 RNA 的表达,并定义了两组受 IL-6 和转录因子 Twist 调节的微小 RNA 的靶基因和功能效应。通过筛选具有异常表达细胞因子 IL-6 和 Twist 的高度耐药和侵袭性 HSCs,我们发现了一小部分。我们通过基于微阵列的全基因组微小 RNA 谱分析证实了在 HSCs 中保守的 let-7 和 miR-181 家族成员上调,随后通过实时聚合酶链反应进行验证。重要的是,let-7 的抑制增加了 HSCs 对索拉非尼和阿霉素的化疗敏感性,而 miR-181 的沉默导致 HSCs 迁移和侵袭减少。在 HSCs 中敲低 IL-6 和 Twist 显著降低了 let-7 和 miR-181 的表达,从而抑制了化疗耐药性和细胞侵袭。我们表明,let-7 直接靶向 SOCS-1 和 caspase-3,而 miR-181 直接靶向 RASSF1A、TIMP3 以及 nemo 样激酶(NLK)。总之,HSCs 中 IL-6 和 Twist 调节的微小 RNA 表达的改变在肿瘤扩散和对化疗的反应中起作用。我们的结果定义了 let-7/miR-181s 的新调节机制,表明 let-7 和 miR-181 可能是消除肝癌恶性肿瘤的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb6/3823102/eeb28b4d8b62/jcmm0016-0160-f1a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验